Press releases

Filter
157 found

Japan’s First PPP to Spearhead Innovation in Global Health

08 Apr 2013

Open access initiative reveals drug hits for deadly neglected tropical diseases

13 Nov 2012

African antimalarial research bears first fruit

28 Aug 2012

MMV assesses risk of resistance

22 Aug 2012

Delivery of child-friendly antimalarial hits the 100 million mark

22 Feb 2012

One step closer to blocking the transmission of malaria

21 Feb 2012

Pyramax® receives positive opinion from the EMA

20 Feb 2012

MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost

19 Dec 2011

New generation of lifesaving medicines and vaccines for the world’s poor now at risk

08 Dec 2011

Marketing authorization for Eurartesim® announced at media roundtable

30 Nov 2011

New dual-acting antimalarial compounds discovered

17 Nov 2011

Partnership reaches important milestone

14 Nov 2011

Patient screening underway for Pyramax® sub-study in Sotuba, Mali

09 Nov 2011

Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities

11 Oct 2011

Molecule moves through preclinical development in record time

02 Sep 2011

Artemisinin’s key impurities identified and made available as reference standards

20 Jun 2011

MMV supports new technique to measure quality of artemisinin

06 Jun 2011

MMV participates in Asia Pacific efforts to eliminate malaria

25 May 2011

Sanofi-aventis and MMV join forces to develop innovative malaria drugs

05 May 2011

"SMS for Life" rolled-out nationwide in the United Republic of Tanzania

18 Apr 2011

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011

International status granted to three not-for-profit organizations in Switzerland

09 Dec 2010

MMV, Novartis and partners discover novel antimalarial drug candidate

03 Sep 2010

MMV becomes first PDP to make its IP freely available for neglected diseases research

16 Aug 2010

MMV to screen Ferrer compound library

15 Jul 2010

AstraZeneca and MMV join efforts in the fight against malaria

28 Jun 2010

Data from MMV-supported research now in the public domain

20 May 2010

MMV and Anacor join hands in hunt for new antimalarial compounds

26 Apr 2010

MMV supports trials of a new preventive treatment option for pregnant women

23 Apr 2010

Pyramax® submitted to EMA for regulatory approval

08 Apr 2010

MMV’s Project of the Year for 2009 goes to Spiroindolones

15 Mar 2010

MMV-GSK compound library screening to be made public

20 Jan 2010

MMV 10th Anniversary Seminars: presentations and video clips

04 Dec 2009

MMV’s President and CEO to step down in 2010

23 Nov 2009

MMV and sanofi-aventis launch ambitious antimalarial monitoring programme

19 Nov 2009

MMV receives $115 million from Gates Foundation

19 Oct 2009

MMV and Treague take development of (+) Mefloquine into Phase I

10 Jul 2009

Dihydroartemisinin-piperaquine submitted to EMEA for regulatory approval

06 Jul 2009

Pfizer and MMV advancing international research efforts in the fight against malaria

22 Apr 2009

MMV and Merck & Co. to develop promising antimalarial compound

18 Mar 2009

MMV and Novartis launch Coartem® Dispersible

20 Feb 2009

MMV and Novartis launch Coartem® Dispersible in Africa

15 Feb 2009

Unique collaboration launches a new malaria medicine to save millions of children

27 Jan 2009

First-ever comprehensive report on the antimalarials market in Uganda shows how understanding markets can help improve access to medicines

05 Nov 2008

MMV signs MOU with sanofi-aventis

22 Oct 2008

Unforgettable launch of MMV-MOH Uganda pilot

22 Sep 2008

Genzyme Corporation and MMV Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria

26 Aug 2008

Spain becomes a major government funder of MMV

31 May 2008

Dacart development halted based on Phase III results

29 Feb 2008

MoH - MMV: Bold intervention being designed in Uganda to deliver subsidized effective antimalarials

01 Oct 2007

US NIH grants MMV over USD 5 mn for malaria research

06 Sep 2007

Start of Phase II trial of intravenous artesunate for children with severe malaria

29 Aug 2007

Uganda and MMV explore innovative ways to give patients access to life-saving antimalarials

09 May 2007

Pivotal clinical trials launched for new artemisinin-based malaria drug combination

25 Jan 2007

Malaria Map: New Tool for Malaria Control

06 Dec 2006

Medicines for Malaria Venture, Higher Colleges of Technology and Global Medical Forum Foundation Collaborate on Innovative Abu Dhabi Bio City Research Initiative to Tackle Malaria

18 Oct 2006

MMV announces a commitment of US$50 million to advance malaria research at President Clinton’s Global Initiative

21 Sep 2006

Pivotal Studies Begin for CDA in sub-Saharan Africa

25 Jul 2006

Pages